Preterm and small-for-gestational-age (SGA) neonates are vulnerable groups that are susceptible to various microbial infections. Vc9Vd2-T cells are critical components of the host immune system and have been demonstrated to play an important role in the defense against viral infection in adults. However, the characteristics of Vc9Vd2-T cells in children, especially the preterm and SGA populations, are poorly understood. Here, we examined the frequency and antiviral function of Vc9Vd2-T cells in neonates, including preterm, SGA and full-term babies. When compared to adults, neonates had a significantly lower percentage of Vc9Vd2-T cells in the blood. Upon influenza virus stimulation, neonatal Vc9Vd2-T cells, especially from preterm and SGA babies, showed markedly decreased and delayed antiviral cytokine responses than those of adults. In addition, the antiviral responses of neonatal Vc9Vd2-T cells were positively correlated with gestational age and birth weight. Finally, a weaker expansion of Vc9Vd2-T cells by isopentenyl pyrophosphate (IPP) was shown in neonates than the expansion in adults. Our data suggest that the depressed antiviral activity and decreased frequency of Vc9Vd2-T cells may likely account for the high susceptibility to microbial infection in neonates, particularly in preterm and SGA babies. Improving Vc9Vd2-T-cell function of neonates may provide a new way to defend against virus infection.
INTRODUCTION
Human neonates, particularly those born prematurely and those that are small for gestational age (SGA), have increased morbidity and mortality from a variety of microbes, including virus infections. The susceptibility to infection in neonates can be attributed to limitations of both innate and adaptive immune mechanisms. These limitations are characterized by qualitative and quantitative immaturity of the immune system in early life. For example, neonatal monocytes have a reduced capacity to amplify signals and to activate adaptive immune cells through upregulated cytokine production and expression. 1, 2 Neonatal dendritic cells (DCs) are also immature in terms of phenotype and function compared to adult DCs. 3 In general, neonates can mount antigen-specific T-cell responses, but their CD4 T-cell responses are often slower to develop, less readily sustained and in general, more easily biased toward a Th2 type response. 4 Even 2-3 years after birth, these young children still have a selective defect in Th1 type responses to cytomegalovirus, whereas their CD8 T-cell responses to cytomegalovirus are normal. 5, 6 Human cd-T cells play an indispensable role in host defense against microbial pathogens.
7,8 Vc9Vd2-T cells are the major cd-T-cell population in peripheral blood in humans, and these cells exhibit characteristics of both innate and adaptive immune responses. [9] [10] [11] It has been shown that human Vc9Vd2-T cells have antiviral activity against different viruses, including influenza virus, through cytolytic and non-cytolytic mechanisms. [12] [13] [14] [15] Vc9Vd2-T cells can directly kill influenza virus-infected cells through the release of perforin and granzyme B. 15 They can also inhibit human influenza virus replication by secretion of antiviral cytokines, such as interferon (IFN)-c. 13 However, little is known about the antiviral activity of Vc9Vd2-T cells in neonates, especially those born prematurely and those that are small for gestational age.
Although cd-T cells constitute only a small proportion of T cells in the peripheral blood in adults, Vc9Vd2-T cells can be specifically expanded in an histocompatibility leukocyte antigen-unrestricted manner by small non-peptidic phosphoantigens (isopentenyl pyrophosphate (IPP)), which are metabolites of isoprenoid biosynthesis pathways. 15 The antiviral activity of Vc9Vd2-T cells is determined by their activation and amplification. It is known that IPP-expanded Vc9Vd2-T cells have more potent antiviral activity against influenza virus than resting Vc9Vd2-T cells. 15 Our previous data in humanized mice has shown that phosphoantigen can control influenza virus infection by selectively amplifying human Vc9Vd2-T cells, 14 suggesting a novel therapeutic strategy for treating influenza through the use of phosphoantigen. However, whether phosphoantigen can mediate amplification of Vc9Vd2-T cells in neonates still remains unknown.
Respiratory virus infection is a major disease burden in newborns. Influenza virus is one of the most common respiratory viruses and contributes to a large proportion of respiratory infectious diseases in children, especially in very young children. In the present study, we investigated cd-T-cell function in early neonatal life by examining cytolytic granules and cytokine expression in both resting and influenza virus-stimulated neonatal Vc9Vd2-T cells, including full-term, preterm and SGA babies. T-cell function was further compared with that of adult cells. The ability to expand in response to IPP stimulation was also examined and compared between neonatal and adult cd-T cells.
MATERIALS AND METHODS

Subjects
The cord blood was collected at the Division of Neonatology in the Department of Pediatrics, Second Hospital of Sichuan University, from January 2010 to March 2012. Informed consent was obtained from the parents of the newborns. Peripheral blood was collected from healthy adult volunteers during the same time period. The research protocol was approved by the Institutional Review Board of the University Hospital of Sichuan University. Neonates recruited in this study had intact membranes, clear amniotic fluid and an Apgar score of o8.7 at 1 and 5 min. No signs of distress or infection during intrauterine life or evidence of congenital anomalies were evident. All samples were collected in sodium heparin tubes.
Cell preparation and influenza H1N1 virus stimulation Peripheral blood mononuclear cells (PBMCs) and cord blood mononuclear cells (CBMCs) were isolated with FicollHypaque (Pharmacia) gradient centrifugation as we have previously described. 16 Human influenza A virus, A/PR/8/34 (H1N1), was kindly provided by the Department of Microbiology, West China School of Preclinical and Forensic Medicine, Sichuan University, and cultured in Madin-Darby canine kidney cells. The virus titer was determined by daily observation of cytopathic effect, and the median tissue culture infective dose (TCID 50 ) was calculated according to the ReedMuench formula. PBMCs were infected with H1N1 virus at a multiplicity of infection (MOI) of 2 and cultured in RPMI-1640 media supplemented with 10% fetal bovine serum (Hyclone, Utah, USA). Four hours before the end of culture, brefeldin A (Sigma-Aldrich, St Louis, MO, USA) was added at a final concentration of 10 mg/ml. Cells were then collected after 12, 24, 36 and 48 h culture, and the perforin, IFN-c and tumornecrosis factor (TNF)-a-secreting cells were examined by intracellular cytokine staining.
Vc9Vd2-T-cell amplification by IPP stimulation
PBMCs and CBMCs (2310 6 cells/well) were cultured in 24-well plates with RPMI-1640 medium supplemented with 10% fetal bovine serum. IPP (Sigma) was added at day 0 and day 3 at a final concentration of 6 mg/ml. Recombinant human interleukin-2 (IL-2; Invitrogen, California, USA) was added at a final concentration of 500 IU/ml every 3 days from day 3. After 14 days of culture, cells were harvested and the percentage of Vc9Vd2-T cells in culture was analyzed by flow cytometry.
Flow cytometric analysis
Cells were stained for cell surface markers with the following antibodies: mouse anti-human T-cell receptor (TCR) Vd2-PE and mouse anti-human CD3-Pacific Blue (BD Biosciences New Jersey, USA) to identify the cd-T cells. After surface staining, the cells were fixed with lysis buffer (eBioscience, California, USA) for 10 min, permeabilized with permeabilization buffer (eBioscience) for 10 min and then stained with antihuman perforin-FITC, anti-human TNF-a antigen-presenting cell and anti-human IFN-c-PE-Cy7 (BD Biosciences), or their respective isotype controls. All samples were acquired with a minimum of 0.1 million events, which were collected on a Gallios flow cytometer (Beckman Coulter California, USA) and analyzed by FlowJo software (version 7.6.5; Tree Star). Forward scatter and side scatter were used to identify lymphocytes, which was used to define cd T cells, including both CD3-and TCRcd-positive cells. The expression of perforin, TNF-a and IFN-c were further examined.
Statistical analysis
Data are expressed as the mean6standard error of the mean. Differences between the normal and stimulated groups were analyzed by paired t-tests. AVONA tests were used to compare the fold change between the groups. P,0.05 was considered to be significant.
RESULTS
Clinical samples
A total of 83 neonates and 10 healthy adults (PB group) were enrolled in this study. There were 23 SGA (term and near term .35-week gestation, birth weight in the lowest 10th percentile) Vc9Vd2-T lymphocytes have impaired antiviral functioninfants, 20 preterm babies (PT group) with 28-35 weeks of gestation and 40 appropriate-for-gestational-age, normal full-term babies (FT group). Of these groups, 51 neonates were delivered through the vagina and 32 by elective cesarean section. The babies of these three groups differed significantly in terms of maternal age, gravidity, gestational age, birth weight, head circumference and mode of delivery (Table 1) . However, the gender distribution and Apgar score among SGA, full-term and preterm neonates were not significantly different ( Table 1) .
Quantity of resting Vc9Vd2-T cells and their antiviral cytokine expression
To determine the basal condition of resting Vc9Vd2-T cells in full-term, preterm and SGA neonates, we compared the percentage of Vc9Vd2-T cells in the cord blood and their antiviral cytokine levels with the Vc9Vd2-T cells in the peripheral blood from healthy adults. As shown in Figure 1a , adults had a significantly higher percentage of Vc9Vd2-T cells in the blood than all groups of neonates. Among neonates, the amount of Vc9Vd2-T cells was the highest in full-term neonates and lowest in preterm ones. Specifically, there were 4%-10%, 1%-3%, 1%-1.5% and less than 1% Vc9Vd2-CD3 1 T cells in the blood of healthy adults, full-term, SGA and preterm neonates, respectively. The perforin expression in resting Vc9Vd2-T cells was also significantly higher in adults than in neonates, whereas there was no difference in perforin expression among full-term, preterm and SGA neonates (Figure 1b) . For IFN-c and TNF-a expressing Vc9Vd2-T cells, there was no significant difference among these four groups (Figure 1c and d) .
Reduced perforin response of neonatal Vc9Vd2-T cells upon influenza virus stimulation
To determine the perforin responses of Vc9Vd2-T cells upon influenza virus stimulation, CBMCs and PBMCs were stimulated with influenza H1N1 virus, and the perforin expression in Vc9Vd2-T cells was analyzed by FACS. As shown in Figure 2a , influenza virus significantly increased perforin expression in Vc9Vd2-T cells from all adults and neonates after 24 h stimulation. Comparing the fold increase of perforin expression in Vc9Vd2-T cells to the basal level, we found that the fold increase of perforin expression in Vc9Vd2-T cells from adults was significantly higher than that from full-term, preterm or SGA neonates after 24 h stimulation. In contrast, there was no significant difference in the fold increase among the neonatal groups (Figure 2b) . To determine the kinetics of the perforin response, we further examined perforin expression over serial time points post virus stimulation. As shown in Figure 2c , perforin expression in Vc9Vd2-T cells reached its peak level at 24 h post-stimulation in adults. Peak expression of perforin was at 36 h in neonates. In addition, the magnitude of perforin expression was lower in neonates than in adults. (Figure 3a and b) . However, the virus did not induce significant IFN-c and TNF-a expression in Vc9Vd2-T cells from preterm neonates, although there was a trend toward an increase over mock after 24 h stimulation. For the fold increase over basal levels of IFN-c and TNF-a expression in Vc9Vd2-T cells, adult Vc9Vd2-T cells had the highest antiviral cytokine response to influenza virus, and the fold increases of IFN-c and TNF-a expression were significantly higher than those in full-term, preterm or SGA neonates after 24 h stimulation. Within neonatal groups, full-term neonatal Vc9Vd2-T cells had the highest cytokine response to influenza virus, and the fold increases were significantly higher than those in preterm or SGA neonates. In contrast, preterm neonatal Vc9Vd2-T cells had the lowest IFN-c and TNF-a responses to influenza virus among the four adult and neonatal groups (Figure 3c and  d) . In the kinetics study, we found that, except for IFN-c expression in full-term neonates, adult Vc9Vd2-T cells mounted peak levels of antiviral cytokine responses at an earlier time point 
Reduced antiviral cytokine response in neonatal
Vc9Vd2-T cells upon influenza virus stimulation We further determined IFN-c and TNF-a responses of Vc9Vd2-T cells induced by influenza virus stimulation. After 24 h stimulation, influenza virus significantly triggered IFN-c and TNF-a expression in Vc9Vd2-T cells from adults, full-term and SGA neonates
Correlation of Vc9Vd2-T-cell perforin and cytokine responses with gestational age and birth weight
We further examined the effects of gestational age and birth weight of neonates on Vc9Vd2-T-cell function. CBMCs of neonates with distinct gestational age or birth weight were stimulated with influenza virus. The expressions of perforin, IFN-c and TNF-a were examined by flow cytometry. As shown in Figure 4 , with the increase of neonatal gestational age, Vc9Vd2-T cell fold increases of perforin, IFN-c and TNF-a expression were also increased, which indicated a positive correlation of the influenza virus-induced Vc9Vd2-T-cell response with gestational age. Similarly, the perforin, IFN-c and TNF-a responses of Vc9Vd2-T cells were also positively correlated with the birth weight of neonates. Expression increased along with the increase of the neonate's birth weight.
Weaker IPP-induced expansion of Vc9Vd2 T cells in neonates Previously, we demonstrated that IPP can efficiently expand Vc9Vd2-T cells in adults. We further examined whether IPP plus IL-2 could expand neonatal cd-T cells. CBMCs were stimulated with IPP plus IL-2 for 2 weeks, and the expansion of Vc9Vd2-T cells was determined by flow cytometry. As shown in Figure 5 , all of the Vc9Vd2-T cells from adults, full-term, preterm and SGA neonates were expanded by IPP plus IL-2 stimulation, which was similar to a previous report. 17 However, the expansion efficiency differed significantly among each group. IPP induced markedly stronger expansion of Vc9Vd2-T cells in adults than in neonates. Among neonates, the fold expansion of Vc9Vd2-T cells was significantly stronger in full-term neonates compared to that in preterm and SGA neonates.
DISCUSSION SGA neonates, defined as those with birth weights below the 10th percentile for gestational age, are a significant public health problem because their smaller size can lead to potential immediate and long-term complications. 18 Preterm infants are also associated with a high rate of perinatal morbidity and mortality. 19 Both of these groups are highly susceptible to life-threatening infections. The susceptibility to infection is due to immature adaptive and innate immune systems. A series of studies have investigated the impaired adaptive immunity. In preterm and SGA neonates, the Th1 response was depressed during pregnancy until birth. In preterm babies, a deficiency of TLR receptors, naïve antigen-presenting cell cells and a lower level of Th1 cytokines expressed by CD4 1 and CD8 1 T cells have been reported. [20] [21] [22] [23] During the first months of life, the innate immune system plays a more important role than the adaptive immune system. 24 However, the functions of monocytes, macrophages, dendritic cells, natural killer cells and neutrophils are also depressed. 24 Lower antigen-DR on CD14 1 monocytes has been shown to depress the reaction to lipopolysaccharide. 25 Additionally, defects in natural killer cell cytotoxicity limited the antiviral response to virus. [26] [27] [28] These impaired immune functions may be attributed to the alteration of innate immune genes modified by the gestational and uterine environments. 19, 22, 29 Vc9Vd2-T cells have potent antiviral functions. Similar to ab T cells, they can mount both type 1 and type 2 responses. The dominant type 1 response plays a significant role in the antiviral reaction. Additionally, Vc9Vd2-T cells have antigenpresenting cell functions and can trigger mature adaptive immune responses. The cytotoxic activity of Vc9Vd2-T cells is major histocompatibility complex-unrestricted and is not dependent on the type of invading virus. [30] [31] [32] [33] [34] [35] [36] Influenza virus is a major causative pathogen of acute respiratory diseases worldwide and accounts for substantial morbidity and mortality of neonates annually, particularly in preterm and SGA infants. Previously, we demonstrated that adult Vc9Vd2-T cells have potent anti-influenza effects. [12] [13] [14] [15] In this study, we continued to examine the antiviral function of neonatal Vc9Vd2-T cells.
We found that the percentage of Vc9Vd2-T cells was lower in full-term neonates compared with Vc9Vd2-T cells in adults, which is consistent with other findings. 36 In addition, we found a significantly lower number of Vc9Vd2-T cells in preterm and SGA babies after birth, compared with full-term neonates. The expression of perforin was also significantly lower in neonatal Vc9Vd2-T cells. Perforin is a pore-forming molecule that allows apoptotic molecules, such as granulysin, to enter and cause osmotic lysis of target cells. IFN-c and TNF-a have direct and indirect antiviral effects. Previously, we demonstrated that adult Vc9Vd2-T cells could kill influenza virus-infected cells and could inhibit viral replication through the production of cytolytic granules and antiviral cytokines. 12, 13, 15 Here, we found that Vc9Vd2-T cells of both adults and full-term neonates expressed significantly increased perforin, IFN-c and TNF-a after influenza virus stimulation. In contrast, there was no obvious enhancement of expression of these molecules in preterm neonatal Vc9Vd2-T cells. Additionally, cytokine expression was increased to a lesser degree in all neonatal Vc9Vd2-T cells than that in adult cells. Furthermore, the 
Vc9Vd2-T lymphocytes have impaired antiviral function
kinetics of antiviral cytokine expression was examined and compared between neonatal and adult Vc9Vd2-T cells. The SGA and preterm neonatal T cells had a delayed response, with peak levels at 36 h, compared to the peak of the adult cells at 24 h. Taken together, neonatal Vc9Vd2-T cells, especially from preterm and SGA neonates, have weaker granule and antiviral cytokine responses upon influenza virus stimulation. The depressed cytokine expression by Vc9Vd2-T cells in preterm and SGA neonates may be attributed to the deficient development of receptor-mediated signaling and the abnormal modification of immune cell genes, which are usually influenced by the appropriate gestational age, uterus environment and special antigen stimulation. [37] [38] [39] Consistent with these findings, we showed that Vc9Vd2-T-cell function was positively correlated with the gestational age and birth weight of neonates.
IPP, a 246-Da molecule with a five-carbon isopentenyl chain and a pyrophosphate moiety, has been structurally identified as the first ligand for human Vc9Vd2-T cells and rapidly induces signal transduction pathways associated with the TCR. 31, 32, 40 It has been demonstrated that natural and synthetic phosphoantigens can selectively expand adult Vc9Vd2-T cells in vitro. 40 We have also previously demonstrated that IPP could efficiently expand adult Vc9Vd2-T cells. In this study, we further showed that IPP could induce the expansion of neonatal Vc9Vd2-T cells, but the degree of expansion was significantly lower than that of adult cells. Additionally, preterm and SGA neonatal Vc9Vd2-T cell expansion was markedly weaker than that of full-term neonates. The decreased responses may be due to the presence of fewer Vc9Vd2 TCRs on Vc9Vd2-T cells in preterm and SGA groups.
In summary, in this study, we demonstrated that neonates, especially those with low birth weight or insufficient gestational age, were born with functionally immature and lower numbers of Vc9Vd2-T cells. Upon influenza virus stimulation, neonatal Vc9Vd2-T cells had weaker and delayed antiviral responses compared to adult Vc9Vd2-T cells. Depressed antiviral activity and a lower frequency of Vc9Vd2-T cells are likely the reasons for the high susceptibility to microbial infection in neonates, particularly preterm and SGA babies. This report, to the best of our knowledge, is the first to describe the impaired antiviral activity of Vc9Vd2-T cells against influenza virus in preterm and SGA neonates. Although the expansion efficacy was low, IPP can still expand neonatal Vc9Vd2-T cell populations to a certain degree, which may suggest a new strategy to improve the antiviral innate immunity at early life stages.
